Brazil

The 2nd Edition of the Global Business Barometer Improves but Executives Still See the Economy and Their Businesses in the Survival Phase

Tuesday, June 30, 2020 - 8:00am

Sentiment in Europe increased the most (from -40.5 to -27.3), followed closely by the Asia-Pacific and North America.

Key Points: 
  • Sentiment in Europe increased the most (from -40.5 to -27.3), followed closely by the Asia-Pacific and North America.
  • Sentiment about the global economy among executives in the Middle East and Africa region, while still up, increased by only 6.9 points, the least among the five regions covered by the barometer.
  • The Global Business Barometer gauges sentiment towards current events and financial market uncertainty and explores how businesses are coping today and planning for the future.
  • The Economist Intelligence Unit is the thought leadership, research and analysis division of The Economist Group and the world leader in global business intelligence for executives.

Sweeping Workplace Changes Expected in a Post-pandemic World, Says Research From The Adecco Group

Tuesday, June 30, 2020 - 8:00am

The Adecco Group, the world's leading HR solutions company, today unveiled the results of its latest study, Resetting Normal: Defining the New Era of Work, examining the expected short- and long-term impact of the pandemic on resetting workplace norms.

Key Points: 
  • The Adecco Group, the world's leading HR solutions company, today unveiled the results of its latest study, Resetting Normal: Defining the New Era of Work, examining the expected short- and long-term impact of the pandemic on resetting workplace norms.
  • The Adecco Group's Chief Executive Officer, Alain Dehaze, said: "The world of work will never return to the 'normal' we knew before the pandemic struck.
  • This research highlights that employee attitudes have shifted and gaps between workforce expectations and entrenched labour market processes have been exposed.
  • As a Fortune Global 500 company, we lead by example, creating shared value that fuels economies and builds better societies.

The 2nd Edition of the Global Business Barometer Improves but Executives Still See the Economy and Their Businesses in the Survival Phase

Tuesday, June 30, 2020 - 8:00am

Sentiment in Europe increased the most (from -40.5 to -27.3), followed closely by the Asia-Pacific and North America.

Key Points: 
  • Sentiment in Europe increased the most (from -40.5 to -27.3), followed closely by the Asia-Pacific and North America.
  • Sentiment about the global economy among executives in the Middle East and Africa region, while still up, increased by only 6.9 points, the least among the five regions covered by the barometer.
  • The Global Business Barometer gauges sentiment towards current events and financial market uncertainty and explores how businesses are coping today and planning for the future.
  • The Economist Intelligence Unit is the thought leadership, research and analysis division of The Economist Group and the world leader in global business intelligence for executives.

MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR™ Sirolimus Drug Eluting Balloon

Tuesday, June 30, 2020 - 7:00am

NYON, Switzerland, June 30, 2020 /PRNewswire/ -- MedAlliance has announced the award of its second CE Mark: SELUTION SLR 014 PTCA, a novel Sirolimus Drug Eluting Balloon (DEB), for the treatment of coronary arterial disease.

Key Points: 
  • NYON, Switzerland, June 30, 2020 /PRNewswire/ -- MedAlliance has announced the award of its second CE Mark: SELUTION SLR 014 PTCA, a novel Sirolimus Drug Eluting Balloon (DEB), for the treatment of coronary arterial disease.
  • Investigators concluded that the data in this study support the safety, efficacy and optimal performance of SELUTION SLR in coronary applications.
  • In February 2020 MedAlliance received CE Mark approval for SELUTION SLR for treatment of peripheral artery disease.
  • Specializes in ground-breaking technology and commercialization of advanced drug device combination products for treatment of coronary and peripheral artery disease.

dreamstock, the Largest Football Player Platform in South America, Launches Player and Professional Club Transfer Matching Business in Europe

Tuesday, June 30, 2020 - 6:49am

TOKYO, June 30, 2020 /PRNewswire/ -- dreamstockhas announced the European expansion of its information technology-based football player and professional club transfer matching business, which has so far mainly been conducted in Brazil.

Key Points: 
  • TOKYO, June 30, 2020 /PRNewswire/ -- dreamstockhas announced the European expansion of its information technology-based football player and professional club transfer matching business, which has so far mainly been conducted in Brazil.
  • dreamstock is the largest football player platform service in South America, with Japan as its headquarters.
  • It has been in operation for two years now, and as of June 1, 2020, it has around 200,000 users registered, including professional and semi-professional players.
  • dreamstock has now grown to become one of the world's largest online selection platform, with approximately 200,000 players registered.

MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR™ Sirolimus Drug Eluting Balloon

Tuesday, June 30, 2020 - 1:00am

NYON, Switzerland, June 30, 2020 /PRNewswire/ -- MedAlliance has announced the award of its second CE Mark: SELUTION SLR 014 PTCA, a novel Sirolimus Drug Eluting Balloon (DEB), for the treatment of coronary arterial disease.

Key Points: 
  • NYON, Switzerland, June 30, 2020 /PRNewswire/ -- MedAlliance has announced the award of its second CE Mark: SELUTION SLR 014 PTCA, a novel Sirolimus Drug Eluting Balloon (DEB), for the treatment of coronary arterial disease.
  • Investigators concluded that the data in this study support the safety, efficacy and optimal performance of SELUTION SLR in coronary applications.
  • In February 2020 MedAlliance received CE Mark approval for SELUTION SLR for treatment of peripheral artery disease.
  • Specializes in ground-breaking technology and commercialization of advanced drug device combination products for treatment of coronary and peripheral artery disease.

Clinical Data of Avifavir to Become Available to International Partners

Monday, June 29, 2020 - 5:17pm

Avifavir (INN: favipiravir) was registered as one of the first global drugs, and the first in the Russian Federation, to treat the coronavirus infection.

Key Points: 
  • Avifavir (INN: favipiravir) was registered as one of the first global drugs, and the first in the Russian Federation, to treat the coronavirus infection.
  • Avifavir has proven to be effective in clinical trials, and we are committed to helping other countries obtain an additional effective treatment for people infected with coronavirus.
  • Please note that all the distribution rights for Avifavir belong to ChemRar Group of Companies and OOO CHROMIS.
  • No other entity or individual is authorized by ChemRar to distribute Avifavir or conduct ANY negotiations on behalf of ChemRar Group of Companies or OOO CHROMIS.

Clinical Data of Avifavir to Become Available to International Partners

Monday, June 29, 2020 - 5:16pm

Avifavir (INN: favipiravir) was registered as one of the first global drugs, and the first in the Russian Federation, to treat the coronavirus infection.

Key Points: 
  • Avifavir (INN: favipiravir) was registered as one of the first global drugs, and the first in the Russian Federation, to treat the coronavirus infection.
  • Avifavir has proven to be effective in clinical trials, and we are committed to helping other countries obtain an additional effective treatment for people infected with coronavirus.
  • Please note that all the distribution rights for Avifavir belong to ChemRar Group of Companies and OOO CHROMIS.
  • No other entity or individual is authorized by ChemRar to distribute Avifavir or conduct ANY negotiations on behalf of ChemRar Group of Companies or OOO CHROMIS.

Locus Listed as a Representative Vendor in Gartner's Market Guide for Vehicle Routing and Scheduling

Monday, June 29, 2020 - 3:00pm

The report gives an overview of the Vehicle Routing and Scheduling market and lists vendors.

Key Points: 
  • The report gives an overview of the Vehicle Routing and Scheduling market and lists vendors.
  • "Vehicle routing and scheduling (VRS) applications are evolving into solutions in which the routing algorithm is almost becoming a secondary feature.
  • "We believe being named by Gartner Market Guide for Vehicle Routing and Scheduling as a Representative Vendor reinforces the value we add to our customers.
  • 1Gartner, "Market Guide for Vehicle Routing and Scheduling," Oscar Sanchez Duran, Bart De Muynck, 23 June 2020.

Locus Listed as a Representative Vendor in Gartner's Market Guide for Vehicle Routing and Scheduling

Monday, June 29, 2020 - 3:00pm

The report gives an overview of the Vehicle Routing and Scheduling market and lists vendors.

Key Points: 
  • The report gives an overview of the Vehicle Routing and Scheduling market and lists vendors.
  • "Vehicle routing and scheduling (VRS) applications are evolving into solutions in which the routing algorithm is almost becoming a secondary feature.
  • "We believe being named by Gartner Market Guide for Vehicle Routing and Scheduling as a Representative Vendor reinforces the value we add to our customers.
  • 1Gartner, "Market Guide for Vehicle Routing and Scheduling," Oscar Sanchez Duran, Bart De Muynck, 23 June 2020.